Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
posted on
Dec 02, 2019 11:12AM
"Do you think we will be able to compare apples and oranges between the Montreal Cognition trial results with what Biogen's phase 2 trial used for it's alzheimer's drug,..?"
Some comparisons can be made, but with the big caveats of there being huge differences in the trial design, patient populations, and endpoints.
BDAZ